BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36542931)

  • 1. MRI characteristics for predicting histological subtypes in patients with uterine cervical adenocarcinoma.
    Mori T; Kato H; Kawaguchi M; Kanayama T; Furui T; Noda Y; Hyodo F; Matsuo M
    Eur J Radiol; 2023 Jan; 158():110612. PubMed ID: 36542931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
    Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
    Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of Morphologic Parameters of the International Endocervical Adenocarcinoma Criteria and Classification System and Correlation With Clinicopathologic Parameters: A Multi-Institutional Study.
    Bulutay P; Haberal N; Özen Ö; Erdem Ö; Zeren EH; Kulac İ; Taskiran Ç; Vatansever D; Ayhan A; Kapucuoğlu N
    Int J Gynecol Pathol; 2022 Sep; 41(5):447-458. PubMed ID: 34856570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.
    Cho WK; Kim HS; Park W; Chang CS; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG
    J Gynecol Oncol; 2022 Nov; 33(6):e71. PubMed ID: 36047374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
    Ren H; Almadani N; Pors J; Leung S; Ho J; Chow C; Ta M; Park KJ; Stolnicu S; Soslow R; Huntsman D; Gilks BC; Hoang L
    Int J Gynecol Pathol; 2021 Nov; 40(6):533-540. PubMed ID: 34612210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome.
    Hodgson A; Olkhov-Mitsel E; Howitt BE; Nucci MR; Parra-Herran C
    J Clin Pathol; 2019 May; 72(5):347-353. PubMed ID: 30679193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance.
    Chen L; Lucas E; Zhang X; Liu Q; Zhuang Y; Lin W; Chen H; Zhou F
    Histopathology; 2022 Jan; 80(2):338-347. PubMed ID: 34455625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
    Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
    Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
    Park KJ
    Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
    Chen L; Niu Y; Wan X; Yu L; Zhang X; Strickland AL; Dong L; Zhou F; Lu W
    BMC Cancer; 2021 Oct; 21(1):1095. PubMed ID: 34635081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
    Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance appearance of gastric-type adenocarcinoma of the uterine cervix in comparison with that of usual-type endocervical adenocarcinoma: a pitfall of newly described unusual subtype of endocervical adenocarcinoma.
    Kido A; Mikami Y; Koyama T; Kataoka M; Shitano F; Konishi I; Togashi K
    Int J Gynecol Cancer; 2014 Oct; 24(8):1474-9. PubMed ID: 25188888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric-Type Adenocarcinoma of the Uterine Cervix: Magnetic Resonance Imaging Features, Clinical Outcomes, and Prognostic Factors.
    Park KJ; Kim MH; Kim JK; Cho KS
    Int J Gynecol Cancer; 2018 Jul; 28(6):1203-1210. PubMed ID: 29683881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
    Cho WK; Kim HS; Park W; Kim YS; Kang J; Kim YB; Kim YS; Kim YJ; Kim KR; Kim JH; Kwon SY; Choi JH; Yoon M; Kim NI
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):154-163. PubMed ID: 36935025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
    Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
    Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis determination of endocervical adenocarcinomas morphologically reclassified as HPV associated or HPV independent.
    Carvalho CF; Costa LBE; Sanches NC; Damas II; Andrade LALA; Vale DB
    Int J Gynaecol Obstet; 2023 Mar; 160(3):993-1000. PubMed ID: 36074054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors.
    Lee Y; Bae H; Kim HS
    Anticancer Res; 2022 Sep; 42(9):4627-4639. PubMed ID: 36039458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
    Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
    Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group).
    Seki T; Kojima A; Okame S; Yamaguchi S; Okamoto A; Tokunaga H; Nishio S; Takei Y; Yokoyama Y; Yoshida M; Teramoto N; Mikami Y; Shimada M; Kigawa J; Takehara K
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.